Genomic characterization of Haemophilus influenzae harbouring an exogenous resistance gene
<b>Introduction.</b> Reports of β-lactamase-producing <i>Haemophilus influenzae</i> are increasing worldwide.<b>Aim</b>. This study aimed to elucidate the molecular characteristics and evolution of β-lactamase-producing <i>H. influenzae</i>.<b>Methodology.</b> A total of 159 clinical isolates were characterized using multi-locus sequence typing. Antimicrobial resistance genes and integrative and conjugative element (ICE) types were identified through PCR and DNA sequencing. The genetic structure of ICE was further investigated using whole-genome sequencing.<b>Results.</b> Out of 159 clinical isolates, 20.8% (<i>n</i>=33) were β-lactamase producers. Thirteen sequence types (STs) were identified. ST 103, 155, 165 and 388 have been identified in previous studies, suggesting that strains with these STs tend to acquire the β-lactamase gene <i>bla</i> <sub>TEM-1</sub>. Among β-lactamase producers, 66.7% (<i>n</i>=22) of <i>bla</i> <sub>TEM-1</sub> were located on ICE. The ICEs could be classified into two groups based on their sequence (types I and II). Among these strains, 2017-Y3 harboured a macrolide resistance gene, <i>mef (A/E)</i>, in ICE. A comparative analysis of the ICE region of this strain and those from other countries suggested that each isolate was derived from ICE type I or II. These regions, including <i>mef (A/E</i>), were similar to those of Tn<i>6822</i>, which is commonly found in <i>Streptococcus</i>.<b>Conclusions.</b> This study revealed several STs associated with the acquisition of β-lactamase genes on ICEs. Additionally, ICE evolution involved the acquisition of exogenous genes. The accumulation of resistance genes in ICE raises concerns regarding the emergence of multidrug-resistant <i>H. influenzae</i>.
Authors
- Shoji Seyama
- Hidemasa Nakaminami (ORCID: https://orcid.org/0000-0003-2889-8257)
- Emi Tanaka (ORCID: https://orcid.org/0000-0003-0583-594X)
- Kei-ichi Uchiya
- Takeaki Wajima (ORCID: https://orcid.org/0000-0001-9506-707X)
- S. S. Hirano
Institutions
- Tokyo University of Pharmacy and Life Sciences (JP)
- Keio University Hospital (JP)
- Meijo University (JP)
Publication Details
- Journal
- Journal of Medical Microbiology
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1099/jmm.0.001904
- Citations
- 1
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.34
Funders
- Takeda Science Foundation
- Japan Society for the Promotion of Science